Arcturus Therapeutics ( ARCT ) Surges 8.7%: Is This an Indication of Further Gains?
Arcturus Therapeutics (ARCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BEDFORD, Mass., Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted ...
Wall Street Analysts See a 98.59% Upside in Anika ( ANIK ) : Can the Stock Really Move This High?
The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ANIKA ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm - Anika Therapeutics ( NASDAQ:ANIK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika ( ANIK ) To Contact Him Directly To Discuss Their Options
Medtronic makes two key additions to its board. How activist Elliott can build shareholder value
The stage seems to be set for a long-term mutually beneficial relationship between the parties.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK - Anika Therapeutics ( NASDAQ:ANIK )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ( "Anika" or the "Company" ) ANIK. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm - Anika Therapeutics ( NASDAQ:ANIK ) , Fluor ( NYSE:FLR )
NEW YORK, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Nutex Health Inc. NUTX, Anika Therapeutics, Inc. ANIK, Fluor Corporation FLR, and Inspire Medical Systems, Inc.
Anika ( ANIK ) Upgraded to Buy: Here's What You Should Know
Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ANIKA ( ANIK ) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm - Anika Therapeutics ( NASDAQ:ANIK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika ( ANIK ) To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anika Therapeutics, Inc. - ANIK - Anika Therapeutics ( NASDAQ:ANIK )
NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ( "Anika" or the "Company" ) ANIK. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
ANIKA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm - Anika Therapeutics ( NASDAQ:ANIK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika ( ANIK ) To Contact Him Directly To Discuss Their Options
Kirby McInerney LLP Announces Investigation Against Anika Therapeutics, Inc. ( ANIK ) on Behalf of Investors - Anika Therapeutics ( NASDAQ:ANIK )
NEW YORK, Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against Anika Therapeutics, Inc. ( "Anika" or the "Company" ) ANIK. The investigation concerns whether Anika and/or certain of its officers have violated the federal securities ...
Anika ( ANIK ) Q2 Revenue Beats by 4%
Anika Therapeutics ( NASDAQ:ANIK ) , a medical technology company focused on joint preservation and regenerative therapy products, released its earnings on July 30, 2025. The key news from the release was that while the company outperformed revenue estimates-reporting $28.2 million ( GAAP ) ...
Anika Therapeutics ( ANIK ) Reports Q2 Loss, Tops Revenue Estimates
Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Anika Reports Second Quarter 2025 Financial Results
Regenerative Solutions revenue up 41% with Integrity™ Implant System ahead of expectations and continued strong Hyalofast® growth. Integrity surpasses full year 2024 performance and is on pace to more than double in ...
Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update - Anika Therapeutics ( NASDAQ:ANIK )
Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function
Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function ...
uniQure ( QURE ) Reports Q2 Loss, Misses Revenue Estimates
uniQure (QURE) delivered earnings and revenue surprises of +22.47% and -26.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Recursion Pharmaceuticals ( RXRX ) Soars 5.8%: Is Further Upside Left in the Stock?
Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BEDFORD, Mass., July 03, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on July 1, 2025, Anika granted non-statutory ...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BEDFORD, Mass., June 05, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 2, 2025, Anika granted non-statutory ...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BEDFORD, Mass., May 12, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global leader in the osteoarthritis ( "OA" ) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May 1, 2025, Anika granted ...
Company News for May 12, 2025
Companies in The News Are: ...
Anika Therapeutics ( ANIK ) Reports Q1 Loss, Misses Revenue Estimates
Anika (ANIK) delivered earnings and revenue surprises of -166.67% and 8.50%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Anika Reports First Quarter 2025 Financial Results
First Quarter 2025 Commercial Channel revenue up ...
Vericel Corporation ( VCEL ) Reports Q1 Loss, Misses Revenue Estimates
Vericel (VCEL) delivered earnings and revenue surprises of -155.56% and 2.73%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Anika Therapeutics Stock?
Investors need to pay close attention to ANIK stock based on the movements in the options market lately.
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 - Anika Therapeutics ( NASDAQ:ANIK )
BEDFORD, Mass., April 25, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK, a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before the opening of the market on Friday, May 9, 2025, followed ...
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
BEDFORD, Mass., April 25, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before the opening of the market on Friday, May 9, ...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BEDFORD, Mass., April 07, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global leader in the Osteoarthritis ( "OA" ) Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced that on April 1, 2025, Anika granted ...
Are Options Traders Betting on a Big Move in Anika Therapeutics ( ANIK ) Stock?
Investors need to pay close attention to Anika Therapeutics (ANIK) stock based on the movements in the options market lately.
Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday - Adobe ( NASDAQ:ADBE ) , American Homes 4 Rent ( NYSE:AMH )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barrington Research cut Anika Therapeutics, Inc. ANIK price target from $25 to $20.
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert - Adobe ( NASDAQ:ADBE ) , Aditxt ( NASDAQ:ADTX )
U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print. Futures of all four benchmark indices declined in premarket trading. President Donald Trump imposed the promised 25% tariffs on steel and aluminum imports on Wednesday.
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aditxt ( NASDAQ:ADTX ) , American Eagle Outfitters ( NYSE:AEO )
Shares of Intel Corporation INTC rose sharply in today's pre-market trading after the company announced a new chief executive officer. The company said its board of directors has appointed Lip-Bu Tan, a former member of Intel's board of directors, as chief executive officer, effective March 18.
Anika Therapeutics ( ANIK ) Reports Q4 Loss, Tops Revenue Estimates
Anika (ANIK) delivered earnings and revenue surprises of -133.33% and 2.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
Full Year 2024 results in line with guidance with Commercial Channel revenue up ...
Anika Completes Divestiture of Parcus Medical - Anika Therapeutics ( NASDAQ:ANIK )
BEDFORD, Mass., March 07, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK, a global leader in the Osteoarthritis Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced the completion of the previously announced planned divestiture of ...
Anika Completes Divestiture of Parcus Medical
Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions ...
Syndax Pharmaceuticals ( SNDX ) Reports Q4 Loss, Lags Revenue Estimates
Syndax (SNDX) delivered earnings and revenue surprises of -1.85% and 65.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Avidity Biosciences, Inc. ( RNA ) Reports Q4 Loss, Tops Revenue Estimates
Avidity Biosciences (RNA) delivered earnings and revenue surprises of 4.76% and 29.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 - Anika Therapeutics ( NASDAQ:ANIK )
BEDFORD, Mass., Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK, a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2024 financial results after the close of the market on Wednesday, March 12, ...
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
BEDFORD, Mass., Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2024 financial results after the close of the market on ...
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference - Anika Therapeutics ( NASDAQ:ANIK )
BEDFORD, Mass., Feb. 25, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc.
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
BEDFORD, Mass., Feb. 25, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal ...
Strength Seen in Stoke Therapeutics ( STOK ) : Can Its 9.4% Jump Turn into More Strength?
Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - Anika Therapeutics ( NASDAQ:ANIK )
BEDFORD, Mass., Dec. 23, 2024 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK, a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the 43rd Annual J.P.
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
BEDFORD, Mass., Dec. 23, 2024 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the 43rd Annual J.P.
Anika To Participate in December 2024 Investor Conferences - Anika Therapeutics ( NASDAQ:ANIK )
BEDFORD, Mass., Nov. 22, 2024 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK, a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conferences.
Anika To Participate in December 2024 Investor Conferences
BEDFORD, Mass., Nov. 22, 2024 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conferences.
New Strong Sell Stocks for November 11th
AMRK, ANIK and ALG have been added to the Zacks Rank #5 (Strong Sell) List on November 11, 2024.
